We have made great progress in recent decades with cures and better treatments for many cancers, but that has not been the case with gliomas — tumors that originate in the brain — and particularly glioblastoma, the most aggressive form. With the assistance and support of families who have been affected by gliomas, we are […]
Q How does scalp cooling mitigate hair loss during chemotherapy? A Scalp cooling prevents chemotherapy-induced alopecia in two ways. First, it reduces blood flow to the scalp. Cooling causes the blood vessels in the scalp to constrict, which reduces the amount of medication reaching the follicles. Secondly, when our scalp’s temperature is lowered, our metabolism is […]
Years of research by Vanderbilt University Medical Center investigators to determine how precancerous cells in the stomach transition to gastric cancer and to develop strategies to prevent this transition have received federal funding to test two potential treatments. The $2.5 million Department of Defense Translational Team Science Award provides funding over four years to launch a […]
Clip In 4 the Cure 2024 brought people together on Sept. 14, 2024, for an inspiring day of cycling and raising money for cancer research. This year’s event was the most successful yet, with more than 400 attendees at GEODIS Park and over $277,000 raised. This support makes a tangible impact on adult and pediatric […]
Remarkable. That’s how Bhagirathbhai Dholaria, MD, described responses to an ongoing clinical trial for patients with relapsed or refractory multiple myeloma who had run out of treatment options. Dholaria, associate professor of Medicine, presented interim results from the Phase 1 trial for a new “off-the-shelf” chimeric antigen receptor-T cell (CAR-T) therapy at the 21st International […]
Vanderbilt University Medical Center will name the new expansion tower for Vanderbilt University Hospital the Jim Ayers Tower in recognition of Janet and Jim Ayers’ philanthropic legacy and abiding interest in improving the health care and quality of life for Tennesseans. The naming of the 15-level, 470,000-square-foot tower, currently under construction between 21st Avenue South […]
Data from a clinical trial shows that a dual immunotherapy regimen plus short-course radiation for the treatment of rectal cancer that is microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) can be effective enough to avoid chemotherapy and colostomy-requiring surgery. The data from the EA2201 study was so promising that the clinical trial is being […]
The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a $1 million grant to support research at Vanderbilt aimed at dramatically expanding the efficacy of immunotherapy for colorectal cancer. Currently, only people with microsatellite instability-high colorectal cancer, which accounts for about 10% of patients, respond to immune checkpoint inhibitors, but Vanderbilt researchers have […]
At one point or another as a little boy you are told, “Get over it.” These three words you wouldn’t think could do much damage, but deep inside they deteriorate a man’s ability to trust his feelings. Feelings are one thing, but trusting your health is a whole other bag of worms. What do you […]
Only half of young cancer patients report discussingfertility preservation Only half of people with early-onset cancers reported discussing fertility preservation options prior to their oncology treatments, according to results of a cross-sectional study published Nov. 12, 2024, in JAMA Network Open. Young patients with thyroid, lung, ovarian and colorectal cancers reported the lowest prevalence of […]
